Long-Term heart risks after rare COVID complication in kids under scrutiny

NCT ID NCT07659847

Recruiting now Knowledge-focused Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at heart health in children five years after they had MIS-C, a rare but serious condition linked to COVID-19. Researchers will compare 90 children who had MIS-C with healthy children of the same age and sex. They will use heart imaging, blood vessel checks, exercise tests, and blood markers to see if any hidden heart problems remain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study finds lasting heart issues, it could guide long-term monitoring and care for children after MIS-C.
What could go wrong: This is an observational study with only 90 participants, so results may not apply to all children. It looks for signs of problems, not treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 COVID-19–associated multisystem inflammatory syndrome in children pediatric multisystem inflammatory disease, COVID-19 related

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) SARS-COV-2 INFECTION

Contacts and locations

Locations

Medical University of Warsaw Children's Clinical Hospital
RECRUITING

Warsaw, Masovian Voivodeship, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.